• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    2/14/23 12:37:55 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SC 13G/A 1 hwkn13gadec22.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14) HAWKINS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 420261109 (CUSIP NUMBER) December 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 52,531 6. Shared Voting Power* 0 7. Sole Dispositive Power* 52,531 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 52,531 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 0.2% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: HAWKINS INC Item 1(b) Address of Issuer's Principal Executive Offices: 2381 ROSEGATE, ROSEVILLE, MINNESOTA 55113 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates) Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 420261109 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2023 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2022
    Get the next $HWKN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

      ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) -- – Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations

      6/11/25 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in the 2025 Wells Fargo Industrials Conference

      ROSEVILLE, Minn., May 20, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the Wells Fargo Industrials Conference on June 10, 2025. The conference will be held at the Loews Chicago from June 10 to June 12, 2025. The conference will consist of fireside chats and one-on-one meetings with senior executives from leading companies in a variety of industries. Hawkins management will participate on June 10, 2025. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinator or Hawkins Investor Relations at ir@hawkinsinc

      5/20/25 5:04:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 9:01:40 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:57 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEF 14A filed by Hawkins Inc.

      DEF 14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary